nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolpidem—CYP1A2—Pentoxifylline—systemic scleroderma	0.0859	0.189	CbGbCtD
Zolpidem—CYP1A2—Leflunomide—systemic scleroderma	0.0819	0.18	CbGbCtD
Zolpidem—CYP2C9—Leflunomide—systemic scleroderma	0.0738	0.163	CbGbCtD
Zolpidem—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.068	0.15	CbGbCtD
Zolpidem—CYP2D6—Captopril—systemic scleroderma	0.053	0.117	CbGbCtD
Zolpidem—CYP2C19—Prednisone—systemic scleroderma	0.0438	0.0966	CbGbCtD
Zolpidem—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0265	0.0584	CbGbCtD
Zolpidem—CYP3A4—Prednisone—systemic scleroderma	0.0212	0.0467	CbGbCtD
Zolpidem—CYP2C9—cardial valve—systemic scleroderma	0.0053	0.462	CbGeAlD
Zolpidem—PTGS1—artery—systemic scleroderma	0.000726	0.0632	CbGeAlD
Zolpidem—PTGS1—endothelium—systemic scleroderma	0.000613	0.0534	CbGeAlD
Zolpidem—PTGS1—blood vessel—systemic scleroderma	0.000566	0.0493	CbGeAlD
Zolpidem—GABRB3—connective tissue—systemic scleroderma	0.000473	0.0412	CbGeAlD
Zolpidem—GABRB2—lung—systemic scleroderma	0.000372	0.0324	CbGeAlD
Zolpidem—CYP2C19—digestive system—systemic scleroderma	0.000296	0.0258	CbGeAlD
Zolpidem—PTGS1—connective tissue—systemic scleroderma	0.00029	0.0253	CbGeAlD
Zolpidem—GABRB3—lung—systemic scleroderma	0.000285	0.0249	CbGeAlD
Zolpidem—Ataxia—Methotrexate—systemic scleroderma	0.000274	0.000512	CcSEcCtD
Zolpidem—Constipation—Mycophenolic acid—systemic scleroderma	0.000274	0.000512	CcSEcCtD
Zolpidem—Pain—Mycophenolic acid—systemic scleroderma	0.000274	0.000512	CcSEcCtD
Zolpidem—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000273	0.000512	CcSEcCtD
Zolpidem—Weight decreased—Prednisone—systemic scleroderma	0.000272	0.000509	CcSEcCtD
Zolpidem—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000272	0.000509	CcSEcCtD
Zolpidem—Hyperglycaemia—Prednisone—systemic scleroderma	0.000271	0.000508	CcSEcCtD
Zolpidem—Cough—Mycophenolate mofetil—systemic scleroderma	0.00027	0.000505	CcSEcCtD
Zolpidem—Hypotension—Lisinopril—systemic scleroderma	0.000269	0.000504	CcSEcCtD
Zolpidem—Dizziness—Captopril—systemic scleroderma	0.000269	0.000503	CcSEcCtD
Zolpidem—Depression—Prednisone—systemic scleroderma	0.000268	0.000501	CcSEcCtD
Zolpidem—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000267	0.0005	CcSEcCtD
Zolpidem—Urticaria—Leflunomide—systemic scleroderma	0.000266	0.000498	CcSEcCtD
Zolpidem—PTGS1—smooth muscle tissue—systemic scleroderma	0.000265	0.0231	CbGeAlD
Zolpidem—Abdominal pain—Leflunomide—systemic scleroderma	0.000265	0.000496	CcSEcCtD
Zolpidem—Body temperature increased—Leflunomide—systemic scleroderma	0.000265	0.000496	CcSEcCtD
Zolpidem—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000265	0.000495	CcSEcCtD
Zolpidem—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000264	0.000493	CcSEcCtD
Zolpidem—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000263	0.000493	CcSEcCtD
Zolpidem—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000263	0.000493	CcSEcCtD
Zolpidem—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000263	0.000493	CcSEcCtD
Zolpidem—Myocardial infarction—Prednisone—systemic scleroderma	0.000263	0.000492	CcSEcCtD
Zolpidem—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000263	0.000492	CcSEcCtD
Zolpidem—Breast disorder—Methotrexate—systemic scleroderma	0.000263	0.000492	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000263	0.000491	CcSEcCtD
Zolpidem—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000262	0.000491	CcSEcCtD
Zolpidem—PTGS1—skin of body—systemic scleroderma	0.000262	0.0228	CbGeAlD
Zolpidem—Hypersensitivity—Azathioprine—systemic scleroderma	0.000262	0.00049	CcSEcCtD
Zolpidem—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000262	0.000489	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000262	0.000489	CcSEcCtD
Zolpidem—Insomnia—Lisinopril—systemic scleroderma	0.000261	0.000488	CcSEcCtD
Zolpidem—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00026	0.000487	CcSEcCtD
Zolpidem—Paraesthesia—Lisinopril—systemic scleroderma	0.000259	0.000484	CcSEcCtD
Zolpidem—Vomiting—Captopril—systemic scleroderma	0.000259	0.000484	CcSEcCtD
Zolpidem—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000258	0.000482	CcSEcCtD
Zolpidem—Dyspnoea—Lisinopril—systemic scleroderma	0.000257	0.000481	CcSEcCtD
Zolpidem—Rash—Captopril—systemic scleroderma	0.000257	0.00048	CcSEcCtD
Zolpidem—Dermatitis—Captopril—systemic scleroderma	0.000256	0.00048	CcSEcCtD
Zolpidem—Somnolence—Lisinopril—systemic scleroderma	0.000256	0.000479	CcSEcCtD
Zolpidem—Headache—Captopril—systemic scleroderma	0.000255	0.000477	CcSEcCtD
Zolpidem—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000255	0.000476	CcSEcCtD
Zolpidem—Dyspepsia—Lisinopril—systemic scleroderma	0.000254	0.000475	CcSEcCtD
Zolpidem—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000253	0.000473	CcSEcCtD
Zolpidem—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000253	0.000473	CcSEcCtD
Zolpidem—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000252	0.000472	CcSEcCtD
Zolpidem—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000252	0.000472	CcSEcCtD
Zolpidem—Infection—Mycophenolate mofetil—systemic scleroderma	0.000251	0.000469	CcSEcCtD
Zolpidem—Decreased appetite—Lisinopril—systemic scleroderma	0.00025	0.000469	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000249	0.000465	CcSEcCtD
Zolpidem—Fatigue—Lisinopril—systemic scleroderma	0.000248	0.000465	CcSEcCtD
Zolpidem—Shock—Mycophenolate mofetil—systemic scleroderma	0.000248	0.000465	CcSEcCtD
Zolpidem—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000248	0.000463	CcSEcCtD
Zolpidem—Hypersensitivity—Leflunomide—systemic scleroderma	0.000247	0.000462	CcSEcCtD
Zolpidem—Pain—Lisinopril—systemic scleroderma	0.000246	0.000461	CcSEcCtD
Zolpidem—Constipation—Lisinopril—systemic scleroderma	0.000246	0.000461	CcSEcCtD
Zolpidem—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000246	0.000461	CcSEcCtD
Zolpidem—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000245	0.000459	CcSEcCtD
Zolpidem—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000244	0.000457	CcSEcCtD
Zolpidem—Diarrhoea—Azathioprine—systemic scleroderma	0.000243	0.000455	CcSEcCtD
Zolpidem—CYP1A2—digestive system—systemic scleroderma	0.000242	0.0211	CbGeAlD
Zolpidem—Nausea—Captopril—systemic scleroderma	0.000242	0.000452	CcSEcCtD
Zolpidem—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000241	0.000451	CcSEcCtD
Zolpidem—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000241	0.00045	CcSEcCtD
Zolpidem—Asthenia—Leflunomide—systemic scleroderma	0.000241	0.00045	CcSEcCtD
Zolpidem—Hallucination—Prednisone—systemic scleroderma	0.00024	0.000448	CcSEcCtD
Zolpidem—Feeling abnormal—Lisinopril—systemic scleroderma	0.000237	0.000444	CcSEcCtD
Zolpidem—Pruritus—Leflunomide—systemic scleroderma	0.000237	0.000444	CcSEcCtD
Zolpidem—Connective tissue disorder—Prednisone—systemic scleroderma	0.000237	0.000443	CcSEcCtD
Zolpidem—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000236	0.000441	CcSEcCtD
Zolpidem—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000236	0.000441	CcSEcCtD
Zolpidem—Dysuria—Methotrexate—systemic scleroderma	0.000235	0.00044	CcSEcCtD
Zolpidem—Dizziness—Azathioprine—systemic scleroderma	0.000235	0.000439	CcSEcCtD
Zolpidem—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000234	0.000437	CcSEcCtD
Zolpidem—CYP3A5—digestive system—systemic scleroderma	0.000233	0.0203	CbGeAlD
Zolpidem—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000232	0.000433	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00023	0.00043	CcSEcCtD
Zolpidem—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.00023	0.00043	CcSEcCtD
Zolpidem—Asthenia—Mycophenolic acid—systemic scleroderma	0.00023	0.000429	CcSEcCtD
Zolpidem—Diarrhoea—Leflunomide—systemic scleroderma	0.000229	0.000429	CcSEcCtD
Zolpidem—CYP2C9—digestive system—systemic scleroderma	0.000229	0.02	CbGeAlD
Zolpidem—Urticaria—Lisinopril—systemic scleroderma	0.000229	0.000428	CcSEcCtD
Zolpidem—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000228	0.000427	CcSEcCtD
Zolpidem—Body temperature increased—Lisinopril—systemic scleroderma	0.000228	0.000426	CcSEcCtD
Zolpidem—Abdominal pain—Lisinopril—systemic scleroderma	0.000228	0.000426	CcSEcCtD
Zolpidem—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000227	0.000424	CcSEcCtD
Zolpidem—Pruritus—Mycophenolic acid—systemic scleroderma	0.000226	0.000424	CcSEcCtD
Zolpidem—Vomiting—Azathioprine—systemic scleroderma	0.000226	0.000422	CcSEcCtD
Zolpidem—Pneumonia—Methotrexate—systemic scleroderma	0.000226	0.000422	CcSEcCtD
Zolpidem—Eye disorder—Prednisone—systemic scleroderma	0.000225	0.000421	CcSEcCtD
Zolpidem—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000225	0.000421	CcSEcCtD
Zolpidem—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000224	0.00042	CcSEcCtD
Zolpidem—Infestation—Methotrexate—systemic scleroderma	0.000224	0.00042	CcSEcCtD
Zolpidem—Infestation NOS—Methotrexate—systemic scleroderma	0.000224	0.00042	CcSEcCtD
Zolpidem—Drowsiness—Methotrexate—systemic scleroderma	0.000224	0.00042	CcSEcCtD
Zolpidem—Rash—Azathioprine—systemic scleroderma	0.000224	0.000419	CcSEcCtD
Zolpidem—Dermatitis—Azathioprine—systemic scleroderma	0.000224	0.000419	CcSEcCtD
Zolpidem—Depression—Methotrexate—systemic scleroderma	0.000224	0.000418	CcSEcCtD
Zolpidem—Flushing—Prednisone—systemic scleroderma	0.000224	0.000418	CcSEcCtD
Zolpidem—Headache—Azathioprine—systemic scleroderma	0.000222	0.000416	CcSEcCtD
Zolpidem—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000222	0.000416	CcSEcCtD
Zolpidem—Dizziness—Leflunomide—systemic scleroderma	0.000222	0.000415	CcSEcCtD
Zolpidem—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000219	0.000411	CcSEcCtD
Zolpidem—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000219	0.00041	CcSEcCtD
Zolpidem—Stomatitis—Methotrexate—systemic scleroderma	0.000219	0.000409	CcSEcCtD
Zolpidem—Conjunctivitis—Methotrexate—systemic scleroderma	0.000218	0.000408	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000218	0.000408	CcSEcCtD
Zolpidem—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000216	0.000404	CcSEcCtD
Zolpidem—Pain—Mycophenolate mofetil—systemic scleroderma	0.000216	0.000404	CcSEcCtD
Zolpidem—Arrhythmia—Prednisone—systemic scleroderma	0.000215	0.000403	CcSEcCtD
Zolpidem—Vomiting—Leflunomide—systemic scleroderma	0.000213	0.000399	CcSEcCtD
Zolpidem—Hypersensitivity—Lisinopril—systemic scleroderma	0.000212	0.000397	CcSEcCtD
Zolpidem—Dizziness—Mycophenolic acid—systemic scleroderma	0.000212	0.000396	CcSEcCtD
Zolpidem—Epistaxis—Methotrexate—systemic scleroderma	0.000212	0.000396	CcSEcCtD
Zolpidem—Rash—Leflunomide—systemic scleroderma	0.000211	0.000396	CcSEcCtD
Zolpidem—Dermatitis—Leflunomide—systemic scleroderma	0.000211	0.000395	CcSEcCtD
Zolpidem—Mental disorder—Prednisone—systemic scleroderma	0.000211	0.000395	CcSEcCtD
Zolpidem—Nausea—Azathioprine—systemic scleroderma	0.000211	0.000395	CcSEcCtD
Zolpidem—Headache—Leflunomide—systemic scleroderma	0.00021	0.000393	CcSEcCtD
Zolpidem—Erythema—Prednisone—systemic scleroderma	0.00021	0.000392	CcSEcCtD
Zolpidem—Malnutrition—Prednisone—systemic scleroderma	0.00021	0.000392	CcSEcCtD
Zolpidem—PTGS1—digestive system—systemic scleroderma	0.000209	0.0182	CbGeAlD
Zolpidem—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000208	0.000389	CcSEcCtD
Zolpidem—Asthenia—Lisinopril—systemic scleroderma	0.000207	0.000387	CcSEcCtD
Zolpidem—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000206	0.000386	CcSEcCtD
Zolpidem—Pruritus—Lisinopril—systemic scleroderma	0.000204	0.000381	CcSEcCtD
Zolpidem—Vomiting—Mycophenolic acid—systemic scleroderma	0.000203	0.000381	CcSEcCtD
Zolpidem—CYP1A2—lung—systemic scleroderma	0.000202	0.0176	CbGeAlD
Zolpidem—Rash—Mycophenolic acid—systemic scleroderma	0.000202	0.000377	CcSEcCtD
Zolpidem—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000202	0.000377	CcSEcCtD
Zolpidem—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000201	0.000375	CcSEcCtD
Zolpidem—Headache—Mycophenolic acid—systemic scleroderma	0.0002	0.000375	CcSEcCtD
Zolpidem—Pharyngitis—Methotrexate—systemic scleroderma	0.0002	0.000374	CcSEcCtD
Zolpidem—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.0002	0.000373	CcSEcCtD
Zolpidem—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.0002	0.000373	CcSEcCtD
Zolpidem—PTGS1—tendon—systemic scleroderma	0.000199	0.0174	CbGeAlD
Zolpidem—Nausea—Leflunomide—systemic scleroderma	0.000199	0.000373	CcSEcCtD
Zolpidem—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000199	0.000372	CcSEcCtD
Zolpidem—Vision blurred—Prednisone—systemic scleroderma	0.000198	0.00037	CcSEcCtD
Zolpidem—Urethral disorder—Methotrexate—systemic scleroderma	0.000197	0.000369	CcSEcCtD
Zolpidem—Diarrhoea—Lisinopril—systemic scleroderma	0.000197	0.000369	CcSEcCtD
Zolpidem—CYP3A5—lung—systemic scleroderma	0.000195	0.017	CbGeAlD
Zolpidem—Ill-defined disorder—Prednisone—systemic scleroderma	0.000195	0.000364	CcSEcCtD
Zolpidem—Visual impairment—Methotrexate—systemic scleroderma	0.000194	0.000363	CcSEcCtD
Zolpidem—Anaemia—Prednisone—systemic scleroderma	0.000194	0.000363	CcSEcCtD
Zolpidem—Agitation—Prednisone—systemic scleroderma	0.000193	0.000361	CcSEcCtD
Zolpidem—Angioedema—Prednisone—systemic scleroderma	0.000192	0.000359	CcSEcCtD
Zolpidem—Dizziness—Lisinopril—systemic scleroderma	0.000191	0.000357	CcSEcCtD
Zolpidem—Nausea—Mycophenolic acid—systemic scleroderma	0.00019	0.000356	CcSEcCtD
Zolpidem—Malaise—Prednisone—systemic scleroderma	0.000189	0.000354	CcSEcCtD
Zolpidem—Vertigo—Prednisone—systemic scleroderma	0.000188	0.000353	CcSEcCtD
Zolpidem—Eye disorder—Methotrexate—systemic scleroderma	0.000188	0.000352	CcSEcCtD
Zolpidem—Syncope—Prednisone—systemic scleroderma	0.000188	0.000352	CcSEcCtD
Zolpidem—Tinnitus—Methotrexate—systemic scleroderma	0.000188	0.000351	CcSEcCtD
Zolpidem—Cardiac disorder—Methotrexate—systemic scleroderma	0.000187	0.00035	CcSEcCtD
Zolpidem—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000186	0.000348	CcSEcCtD
Zolpidem—Loss of consciousness—Prednisone—systemic scleroderma	0.000184	0.000345	CcSEcCtD
Zolpidem—Vomiting—Lisinopril—systemic scleroderma	0.000183	0.000343	CcSEcCtD
Zolpidem—Rash—Lisinopril—systemic scleroderma	0.000182	0.00034	CcSEcCtD
Zolpidem—Dermatitis—Lisinopril—systemic scleroderma	0.000182	0.00034	CcSEcCtD
Zolpidem—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000181	0.000339	CcSEcCtD
Zolpidem—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000181	0.000339	CcSEcCtD
Zolpidem—Hypertension—Prednisone—systemic scleroderma	0.000181	0.000339	CcSEcCtD
Zolpidem—Chills—Methotrexate—systemic scleroderma	0.000181	0.000338	CcSEcCtD
Zolpidem—Headache—Lisinopril—systemic scleroderma	0.000181	0.000338	CcSEcCtD
Zolpidem—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000179	0.000334	CcSEcCtD
Zolpidem—Myalgia—Prednisone—systemic scleroderma	0.000179	0.000334	CcSEcCtD
Zolpidem—Arthralgia—Prednisone—systemic scleroderma	0.000179	0.000334	CcSEcCtD
Zolpidem—Anxiety—Prednisone—systemic scleroderma	0.000178	0.000333	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000177	0.000332	CcSEcCtD
Zolpidem—Discomfort—Prednisone—systemic scleroderma	0.000176	0.00033	CcSEcCtD
Zolpidem—Mental disorder—Methotrexate—systemic scleroderma	0.000176	0.00033	CcSEcCtD
Zolpidem—Erythema—Methotrexate—systemic scleroderma	0.000175	0.000328	CcSEcCtD
Zolpidem—Malnutrition—Methotrexate—systemic scleroderma	0.000175	0.000328	CcSEcCtD
Zolpidem—CYP3A4—digestive system—systemic scleroderma	0.000175	0.0152	CbGeAlD
Zolpidem—PTGS1—lung—systemic scleroderma	0.000175	0.0152	CbGeAlD
Zolpidem—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000173	0.000323	CcSEcCtD
Zolpidem—CYP2D6—digestive system—systemic scleroderma	0.000172	0.015	CbGeAlD
Zolpidem—Dysgeusia—Methotrexate—systemic scleroderma	0.000172	0.000321	CcSEcCtD
Zolpidem—Nausea—Lisinopril—systemic scleroderma	0.000171	0.00032	CcSEcCtD
Zolpidem—Anaphylactic shock—Prednisone—systemic scleroderma	0.000171	0.00032	CcSEcCtD
Zolpidem—Oedema—Prednisone—systemic scleroderma	0.000171	0.00032	CcSEcCtD
Zolpidem—Infection—Prednisone—systemic scleroderma	0.00017	0.000318	CcSEcCtD
Zolpidem—Back pain—Methotrexate—systemic scleroderma	0.00017	0.000317	CcSEcCtD
Zolpidem—Shock—Prednisone—systemic scleroderma	0.000168	0.000315	CcSEcCtD
Zolpidem—Nervous system disorder—Prednisone—systemic scleroderma	0.000168	0.000314	CcSEcCtD
Zolpidem—Tachycardia—Prednisone—systemic scleroderma	0.000167	0.000313	CcSEcCtD
Zolpidem—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000167	0.000312	CcSEcCtD
Zolpidem—Skin disorder—Prednisone—systemic scleroderma	0.000166	0.000311	CcSEcCtD
Zolpidem—Hyperhidrosis—Prednisone—systemic scleroderma	0.000165	0.00031	CcSEcCtD
Zolpidem—Vision blurred—Methotrexate—systemic scleroderma	0.000165	0.000309	CcSEcCtD
Zolpidem—Anorexia—Prednisone—systemic scleroderma	0.000163	0.000305	CcSEcCtD
Zolpidem—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000163	0.000304	CcSEcCtD
Zolpidem—Anaemia—Methotrexate—systemic scleroderma	0.000162	0.000303	CcSEcCtD
Zolpidem—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000161	0.0003	CcSEcCtD
Zolpidem—Rash—Mycophenolate mofetil—systemic scleroderma	0.000159	0.000298	CcSEcCtD
Zolpidem—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000159	0.000298	CcSEcCtD
Zolpidem—Headache—Mycophenolate mofetil—systemic scleroderma	0.000158	0.000296	CcSEcCtD
Zolpidem—Malaise—Methotrexate—systemic scleroderma	0.000158	0.000296	CcSEcCtD
Zolpidem—Vertigo—Methotrexate—systemic scleroderma	0.000157	0.000295	CcSEcCtD
Zolpidem—Leukopenia—Methotrexate—systemic scleroderma	0.000157	0.000294	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000156	0.000292	CcSEcCtD
Zolpidem—Insomnia—Prednisone—systemic scleroderma	0.000155	0.00029	CcSEcCtD
Zolpidem—Paraesthesia—Prednisone—systemic scleroderma	0.000154	0.000288	CcSEcCtD
Zolpidem—Cough—Methotrexate—systemic scleroderma	0.000153	0.000286	CcSEcCtD
Zolpidem—Dyspepsia—Prednisone—systemic scleroderma	0.000151	0.000282	CcSEcCtD
Zolpidem—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00015	0.000281	CcSEcCtD
Zolpidem—Arthralgia—Methotrexate—systemic scleroderma	0.000149	0.000279	CcSEcCtD
Zolpidem—Myalgia—Methotrexate—systemic scleroderma	0.000149	0.000279	CcSEcCtD
Zolpidem—Chest pain—Methotrexate—systemic scleroderma	0.000149	0.000279	CcSEcCtD
Zolpidem—Decreased appetite—Prednisone—systemic scleroderma	0.000149	0.000278	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000148	0.000277	CcSEcCtD
Zolpidem—Fatigue—Prednisone—systemic scleroderma	0.000148	0.000276	CcSEcCtD
Zolpidem—Discomfort—Methotrexate—systemic scleroderma	0.000147	0.000276	CcSEcCtD
Zolpidem—Constipation—Prednisone—systemic scleroderma	0.000146	0.000274	CcSEcCtD
Zolpidem—Confusional state—Methotrexate—systemic scleroderma	0.000144	0.00027	CcSEcCtD
Zolpidem—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000143	0.000268	CcSEcCtD
Zolpidem—Infection—Methotrexate—systemic scleroderma	0.000142	0.000266	CcSEcCtD
Zolpidem—Feeling abnormal—Prednisone—systemic scleroderma	0.000141	0.000264	CcSEcCtD
Zolpidem—Nervous system disorder—Methotrexate—systemic scleroderma	0.00014	0.000262	CcSEcCtD
Zolpidem—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00014	0.000262	CcSEcCtD
Zolpidem—Skin disorder—Methotrexate—systemic scleroderma	0.000139	0.00026	CcSEcCtD
Zolpidem—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000138	0.000259	CcSEcCtD
Zolpidem—Anorexia—Methotrexate—systemic scleroderma	0.000136	0.000255	CcSEcCtD
Zolpidem—Urticaria—Prednisone—systemic scleroderma	0.000136	0.000254	CcSEcCtD
Zolpidem—Body temperature increased—Prednisone—systemic scleroderma	0.000135	0.000253	CcSEcCtD
Zolpidem—Abdominal pain—Prednisone—systemic scleroderma	0.000135	0.000253	CcSEcCtD
Zolpidem—Hypotension—Methotrexate—systemic scleroderma	0.000134	0.00025	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.00013	0.000244	CcSEcCtD
Zolpidem—Insomnia—Methotrexate—systemic scleroderma	0.000129	0.000242	CcSEcCtD
Zolpidem—Paraesthesia—Methotrexate—systemic scleroderma	0.000128	0.00024	CcSEcCtD
Zolpidem—Dyspnoea—Methotrexate—systemic scleroderma	0.000128	0.000239	CcSEcCtD
Zolpidem—Somnolence—Methotrexate—systemic scleroderma	0.000127	0.000238	CcSEcCtD
Zolpidem—Hypersensitivity—Prednisone—systemic scleroderma	0.000126	0.000236	CcSEcCtD
Zolpidem—Dyspepsia—Methotrexate—systemic scleroderma	0.000126	0.000236	CcSEcCtD
Zolpidem—Decreased appetite—Methotrexate—systemic scleroderma	0.000124	0.000233	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000123	0.000231	CcSEcCtD
Zolpidem—Fatigue—Methotrexate—systemic scleroderma	0.000123	0.000231	CcSEcCtD
Zolpidem—Asthenia—Prednisone—systemic scleroderma	0.000123	0.00023	CcSEcCtD
Zolpidem—Pain—Methotrexate—systemic scleroderma	0.000122	0.000229	CcSEcCtD
Zolpidem—Pruritus—Prednisone—systemic scleroderma	0.000121	0.000227	CcSEcCtD
Zolpidem—Feeling abnormal—Methotrexate—systemic scleroderma	0.000118	0.000221	CcSEcCtD
Zolpidem—Diarrhoea—Prednisone—systemic scleroderma	0.000117	0.000219	CcSEcCtD
Zolpidem—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000117	0.000219	CcSEcCtD
Zolpidem—Urticaria—Methotrexate—systemic scleroderma	0.000114	0.000213	CcSEcCtD
Zolpidem—Dizziness—Prednisone—systemic scleroderma	0.000113	0.000212	CcSEcCtD
Zolpidem—Abdominal pain—Methotrexate—systemic scleroderma	0.000113	0.000212	CcSEcCtD
Zolpidem—Body temperature increased—Methotrexate—systemic scleroderma	0.000113	0.000212	CcSEcCtD
Zolpidem—Vomiting—Prednisone—systemic scleroderma	0.000109	0.000204	CcSEcCtD
Zolpidem—Rash—Prednisone—systemic scleroderma	0.000108	0.000202	CcSEcCtD
Zolpidem—Dermatitis—Prednisone—systemic scleroderma	0.000108	0.000202	CcSEcCtD
Zolpidem—Headache—Prednisone—systemic scleroderma	0.000107	0.000201	CcSEcCtD
Zolpidem—Hypersensitivity—Methotrexate—systemic scleroderma	0.000105	0.000197	CcSEcCtD
Zolpidem—Asthenia—Methotrexate—systemic scleroderma	0.000103	0.000192	CcSEcCtD
Zolpidem—Nausea—Prednisone—systemic scleroderma	0.000102	0.00019	CcSEcCtD
Zolpidem—Pruritus—Methotrexate—systemic scleroderma	0.000101	0.000189	CcSEcCtD
Zolpidem—Diarrhoea—Methotrexate—systemic scleroderma	9.79e-05	0.000183	CcSEcCtD
Zolpidem—Dizziness—Methotrexate—systemic scleroderma	9.46e-05	0.000177	CcSEcCtD
Zolpidem—Vomiting—Methotrexate—systemic scleroderma	9.09e-05	0.00017	CcSEcCtD
Zolpidem—Rash—Methotrexate—systemic scleroderma	9.02e-05	0.000169	CcSEcCtD
Zolpidem—Dermatitis—Methotrexate—systemic scleroderma	9.01e-05	0.000169	CcSEcCtD
Zolpidem—Headache—Methotrexate—systemic scleroderma	8.96e-05	0.000168	CcSEcCtD
Zolpidem—Nausea—Methotrexate—systemic scleroderma	8.49e-05	0.000159	CcSEcCtD
